These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8062197)

  • 21. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Steele CB; Li J; Huang B; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.
    Gilliland FD; Becker TM; Key CR; Samet JM
    Cancer; 1994 Apr; 73(8):2192-9. PubMed ID: 8156525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).
    Danley KL; Richardson JL; Bernstein L; Langholz B; Ross RK
    Cancer Causes Control; 1995 Nov; 6(6):492-8. PubMed ID: 8580296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society.
    Fleshner NE; Herr HW; Stewart AK; Murphy GP; Mettlin C; Menck HR
    Cancer; 1996 Oct; 78(7):1505-13. PubMed ID: 8839558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.
    Hoffman RM; Gilliland FD; Eley JW; Harlan LC; Stephenson RA; Stanford JL; Albertson PC; Hamilton AS; Hunt WC; Potosky AL
    J Natl Cancer Inst; 2001 Mar; 93(5):388-95. PubMed ID: 11238701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Black-white differences in survival from late-stage prostate cancer.
    Polednak AP
    Ethn Dis; 2003; 13(2):220-5. PubMed ID: 12785419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
    Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
    Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base.
    Martin JM; Handorf EA; Kutikov A; Uzzo RG; Bekelman JE; Horwitz EM; Smaldone MC
    Cancer; 2014 Jul; 120(14):2114-21. PubMed ID: 24737481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Black-white differences in tumor grade (aggressiveness) at diagnosis of prostate cancer, 1992-1998.
    Polednak AP
    Ethn Dis; 2002; 12(4):536-40. PubMed ID: 12477140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
    Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
    J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
    Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
    Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of African-American ethnic background with survival in men with metastatic prostate cancer.
    Thompson I; Tangen C; Tolcher A; Crawford E; Eisenberger M; Moinpour C
    J Natl Cancer Inst; 2001 Feb; 93(3):219-25. PubMed ID: 11158191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethnic minorities (African American and Hispanic) males prefer prostate cryoablation as aggressive treatment of localized prostate cancer.
    Kim FJ; Werahera PN; Sehrt DE; Gustafson D; Silva RD; Molina WR
    Can J Urol; 2014 Jun; 21(3):7305-11. PubMed ID: 24978362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
    Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA
    J Clin Oncol; 2010 Feb; 28(6):1069-74. PubMed ID: 20100957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.